Trial intelligence / Profile preview

Treatment of Preoperative Anaemia in Patients with Urogenital Cancer: Intravenous Iron Isomaltoside 1000 (Monofer) vs Saline

2013-004979-13Phase 4Terminated

Sponsor
Rigshospitalet
Start
Jan 2014
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in iron deficiency anemia (IDA), anemia of inflammation (AI) and anaemia comparing Monofer arm with Saline placebo arm (2 arms). Started Jan 2014; status: terminated.

02

Drugs

ferric derisomaltose
03

Conditions

iron deficiency anemia (IDA)anemia of inflammation (AI)anaemia

Beyond the preview

Go deeper on 2013-004979-13.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-004979-13.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call